Diabetes Drug’s New Weight Loss Formula Fuels Cost-Benefit Debate
Ozempic’s peppy ads suggest that people who use it might lose weight, but also include a disclaimer: that it “is not a weight loss drug.” Now — as Wegovy — it is.
Julie Appleby
New Alzheimer’s Drug Manufacturer Launches Controversial Campaign
Facing a host of challenges, Aduhelm’s makers are running an educational campaign directed at consumers who are worried about whether their forgetfulness is a sign of disease.
Is Your Living Room the Future of Hospital Care?
Hospital-level care at home is poised to grow after more than a decade, boosted both by hospitals eager to ease overcrowding and growing interest by insurers who want to slow health care spending.
Time to Say Goodbye to Some Insurers’ Waivers for COVID Treatment Fees
Starting at the end of last year — and continuing into the spring — a growing number of insurers are quietly ending fee waivers for COVID treatment on some or all policies.
Hospital Prices Just Got a Lot More Transparent. What Does This Mean for You?
There is disagreement whether new requirements for hospitals to post price information will curtail prices and create better-informed consumers.
5 Things to Know About a COVID Vaccine: It Won’t Be a ‘Magic Wand’
It's very unlikely that a vaccine against the coronavirus will be as effective as the one against measles, for example.
Conspiracy Theories Aside, Here’s What Contact Tracers Really Do
In the midst of the COVID-19 epidemic, contact tracing is downright buzzy, and not always in a good way.
Trump’s New Order For Medicare Packs Potential Rise In Patients’ Costs
Vowing to protect Medicare with “every ounce of strength,” President Donald Trump spoke this month to a cheering crowd in Florida.
Short-Term Health Plans Hold Savings For Consumers, Profits For Brokers And Insurers
Sure, they’re less expensive for consumers, but short-term health policies have another side: They’re highly profitable for insurers and offer hefty sales commissions.
Pages
